Posted inNews
Novo Nordisk Alzheimer’s Drug Trials Fail, Triggering Sharp Drop in NVO Stock: What This Means for Patients and Investors
Written by Swikblog Research Desk | Published: November 24, 2025 Novo Nordisk faces major setback as its Alzheimer’s drug trials report no meaningful benefit. In a major blow to one…







